Package 68001-629-26

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68001-629-26
Digits Only 6800162926
Product NDC 68001-629
Product ID 68001-629_28d93c64-a421-37e6-e063-6294a90ab77d
Description

1 VIAL, SINGLE-USE in 1 CARTON (68001-629-26) / 25 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2025-01-07
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

DOXORUBICIN HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "28d93c64-a421-37e6-e063-6294a90ab77d", "openfda": {"upc": ["0368001629362", "0368001629263"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["b8b66e93-0813-4876-b291-8d7c36a99807"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (68001-629-26)  / 25 mL in 1 VIAL, SINGLE-USE", "package_ndc": "68001-629-26", "marketing_start_date": "20250107"}, {"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (68001-629-36)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "68001-629-36", "marketing_start_date": "20250107"}], "brand_name": "DOXORUBICIN HYDROCHLORIDE", "product_id": "68001-629_28d93c64-a421-37e6-e063-6294a90ab77d", "dosage_form": "INJECTION, SUSPENSION, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "68001-629", "generic_name": "DOXORUBICIN HYDROCHLORIDE", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DOXORUBICIN HYDROCHLORIDE", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA215178", "marketing_category": "ANDA", "marketing_start_date": "20250107", "listing_expiration_date": "20261231"}